Atara Biotherapeutics (AT20.F) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-2.76
-0.8
1.17
3.13

Details

Expected EPS
-0.05697158015999999
Actual EPS
0.1635729
Surprise EPS
0.22
Surprise Percent
+387.11%

Description

Atara Biotherapeutics (AT20.F) has reported earnings of 0.1635729 per share for Q3 2025.

0 Comments

Share your thoughts